Phyto science

It is my pleasure to welcome you to Canna Therapeutic.

The company was founded in October 2016 in Copenhagen. Canna Therapeutic is a biotechnology and phyto-science company that employee approximately 25 people. We are specializing innovative treatments using EU-GMP pharma-grade medical cannabis and phyto-science.

The company is developing a portfolio of API’s from various cannabis compounds as well as drug candidates, originating from the cannabis plant. We also supply dried products to selected markets in EU-GMP pharmaceutical quality.

Behind the scene there is a group of dedicated and highly motivated people with many years of experience in biotech, analytical chemistry, cannabis industry, agriculture, innovation and quality assurance.

Steen Pontoppidan,
Chief Executive Officer and Founder


We are a professional and dedicated team with experts from all over the world. We started the company to improve the quality of life for our patients. We have many partners and alliances that help us explore and exploit the potential of the pharmaceutical cannabis industry.

At Canna Therapeutic, we believe that gathering all the relevant expertise is the key to develop a drug and bring it to the market.

Our business model is based on collaboration and our partnerships illustrate that belief. Business development is an integral part of our business strategy and is decisive to support our dynamic growth.

We welcome opportunities for alliances or partnerships with business partners who could bring our drug candidates to the market and allow patients to access our innovative therapeutic solutions.

We are open to different types of alliances that could enhance the project value and be beneficial for both partners. Regarding our BD & L strategy and the business objectives of our partners, we are prone to design an adapted collaborative approach for a mutually beneficial agreement.

If you are interested in pursuing a collaboration opportunity or investment with Canna Therapeutic, please feel free to contact us.

The true challenge is to stay on track of the right combination of exploration and exploitation and as such being an ambidextrous organization.

Canna Therapeutic Strategy

Canna Therapeutic is an innovative phyto science company that focuses on discovering, developing and commercializing cannabinoid-based medicine to patients, on a global scale. Within the next five years we will be among the top of the global pharmaceutical cannabis industry and setting the new standards for EU-GMP pharma-grade cannabis.

Canna Therapeutic

Canna Therapeutic are bringing medical cannabis into the future with new and innovative pharma-grade treatments for patients. Our EU-GMP standard products will be prescribed for a range of indications including neuropathic pain, pain relief of cancerous sources, inflammatory bowel disease, post-traumatic stress disorder, Parkinson’s, epileptic seizures and more.

EU GMP Product Portfolio

Our products are covered by European, Canadian and Israeli regulatory requirements.

As one of the world’s leading producers of cannabinoid based medicine, we stand on the frontline of the challenge of quality, affordability and availability. It’s was our ambition when we started the company, that everyone who needs our essential products, should be able to access them, at prices that they can afford.


Setting the new standards for medical cannabis

Press the + sign below to read more!



As regulation spreads across the globe, more than 40 countries are adopting regulations that allow the use of cannabis for medical purposes. Canna Therapeutic’s focus and operations already takes the entire value chain, from genetics, cultivation and production to sales and distribution into account.

Our goal is to meet the demands of EU-GMP pharma-grade cannabis for patients, doctors and pharmacies around the world. As medical cannabis markets are growing rapitly on a global scale, there is a need for a global company that can provide safe products and quidience to patients and professionals.



Our focus areas include (but are not limited to)

– Pain

– Antibiotic resistant bacteria

– Inflammatory bowel disease

– Pharmaceutical dermatology

– Dependency support

– Cancer

– Geriatrics


It is important that patients know that their medicine is consistent, save and reliable. Furthermore all patients recieve the active ingredience the producers are claiming, moreover, that it doesn’t contain any harmful ingredients such as pesticides, mol, and chemicals.



Canna Therapeutic has installed an analytic platform where chromatography and mass spectrometric equipment suited for profiling and quantitation of volatile as well as non-volatile components plays an essential role in characterizing the plant. Furthermore, we have established in-house models for in-vito and in vi-vivo screening.



In order to meet the demands of EU-GMP pharma-grade cannabis we have teamed up with the best growers and scientist from around the globe. We will supply a variety of pharma-grade cannabis products for the global marked and have already made several distribution agreements and joint ventures.

The EU-GMP facility are among the top of the worlds leading facilities, and we are proud that we can produce, analyze and supply the best EU-GMP cannabis on the marked.



There are many ways to extract and purifying solvents from plants. In order to differentiate our product portfolio we have all extraction methods lined up in the facility. The chosen extraction method depend on the products at hand, but we have the following extraction facilities established:

  • Gas extraction
  • Steam extraction
  • Solvent extraction


In partnership with patients

Our experienced experts are people living with serious chronic diseases, including patients and family members. The patients and their experience provide us with disease-specific insights that can be used to develop scientific-based medicine.

Such insights can potentially pave the way for our research and development of innovative treatments and programs, that can support people with serious chronic diseases to achieve a better quality of life.

Unsolicited applications

We are always looking for talented people, and we welcome you to send your CV and a cover letter, detailing which types of positions you are interested in and what your motivation is to join Canna Therapeutic.

All unsolicited applications must be submitted to

Your data will be stored for up to two years, and if, during that time, your profile matches any vacancies, we will contact you to arrange an interview. After two years, your application, along with your personal data, will be deleted.

If you do not want us to store your application for up to 2 years, let us know at any time, and we will delete your application, along with your personal data, promptly.

We look forward to hearing from you.

Contact Canna Therapeutic:

Copyright Canna Therapeutic (C) 2018

© Copyright - Canna-therapeutic